Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

515.46
-12.4500-2.36%
Post-market: 515.460.00000.00%19:30 EDT
Volume:266.87K
Turnover:138.11M
Market Cap:22.11B
PE:18.44
High:530.50
Open:527.94
Low:513.72
Close:527.91
52wk High:609.35
52wk Low:303.09
Shares:42.89M
Float Shares:39.35M
Volume Ratio:0.59
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.45
PE(LYR):18.50

Loading ...

aTyr Pharma Q2 Net Loss Narrows

Reuters
·
Aug 08

Inogen Q2 Revenue up Driven by Higher Demand for Portable Oxygen Concentrators

Reuters
·
Aug 07

United Therapeutics CEO Martine Rothblatt Disposes of 9,595 Common Shares Worth $4.98 Million

Reuters
·
Aug 07

Buy Rating Reiterated on United Therapeutics as Diversified Pipeline Offsets Near-Term Headwinds; $660 Price Target Maintained

TIPRANKS
·
Aug 07

United Therapeutics is Maintained at Outperform by RBC Capital

Dow Jones
·
Aug 07

United Therapeutics' Q2 Tyvaso Miss Reflects Competition; IPF Outreach Set to Expand, Morgan Stanley Says

MT Newswires Live
·
Aug 06

United Therapeutics Corp. : Wells Fargo Cuts Target Price to $700 from $738

THOMSON REUTERS
·
Aug 06

Morgan Stanley Adjusts PT on United Therapeutics to $515 From $516, Maintains Equalweight Rating

MT Newswires Live
·
Aug 06

United Therapeutics Balances Tyvaso Woes With Pipeline Wins

TIPRANKS
·
Aug 06

Zevra Therapeutics Q2 Revenue Rises 53% on Miplyffa Sales

Reuters
·
Aug 06

Biopharma Firm MannKind Q2 Posts Net Loss on Product Launch Expenses

Reuters
·
Aug 06

Vanda Pharmaceuticals Q2 Loss Widens on Lower Sales, Higher Costs

Reuters
·
Aug 06

United Therapeutics Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

United Therapeutics Q2 Net Income Rises, Revenue Falls

MT Newswires Live
·
Aug 05

United Therapeutics Q2 2026 earnings: Lower taxes lift EPS as revenue slips

TradingKey
·
Aug 05

United Therapeutics Q2 Revenue Misses Estimates on Ebulized Tyvaso Weakness

Reuters
·
Aug 05

Stock Track | United Therapeutics Plunges 7.46% in Pre-market After Q2 Revenue Misses Estimates

Stock Track
·
Aug 05

Earnings Flash (UTHR) United Therapeutics Posts Q2 EPS $7.27, vs. FactSet Est of $6.86

MT Newswires Live
·
Aug 05

United Therapeutics Q2 Revenue USD 783.3 Million Vs. IBES Estimate USD 805.6 Million

Reuters
·
Aug 05

United Therapeutics Q2 EPS $7.27 Beats $6.88 Estimate, Sales $783.300M Miss $805.645M Estimate

Benzinga Earnings
·
Aug 05